RhumbLine Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Buy |
|
|||||
|
2025
Q1 | $20.4M | Sell |
|
|||||
|
2024
Q4 | $20.6M | Buy |
|
|||||
|
2024
Q3 | $18.5M | Sell |
|
|||||
|
2024
Q2 | $18.1M | Sell |
|
|||||
|
2024
Q1 | $22.3M | Sell |
|
|||||
|
2023
Q4 | $22.9M | Sell |
|
|||||
|
2023
Q3 | $24.3M | Sell |
|
|||||
|
2023
Q2 | $23.5M | Buy |
|
|||||
|
2023
Q1 | $26.7M | Buy |
|
|||||
|
2022
Q4 | $28.8M | Buy |
|
|||||
|
2022
Q3 | $24.1M | Buy |
|
|||||
|
2022
Q2 | $27.6M | Buy |
|
|||||
|
2022
Q1 | $25.2M | Sell |
|
|||||
|
2021
Q4 | $20.8M | Buy |
|
|||||
|
2021
Q3 | $20M | Sell |
|
|||||
|
2021
Q2 | $28M | Buy |
|
|||||
|
2021
Q1 | $24.6M | Sell |
|
|||||
|
2020
Q4 | $24.9M | Sell |
|
|||||
|
2020
Q3 | $22.9M | Buy |
|
|||||
|
2020
Q2 | $8.3M | Buy |
|
|||||
|
2020
Q1 | $7.25M | Buy |
|
|||||
|
2019
Q4 | $9.79M | Buy |
|
|||||
|
2019
Q3 | $8.21M | Buy |
|
|||||
|
2019
Q2 | $9.13M | Buy |
|
|||||
|
2019
Q1 | $8.23M | Buy |
|
|||||
|
2018
Q4 | $7.13M | Sell |
|
|||||
|
2018
Q3 | $10.1M | Sell |
|
|||||
|
2018
Q2 | $10.6M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $6.91M | Sell |
|
|||||
|
2015
Q4 | $7.49M | Buy |
|
|||||
|
2015
Q3 | $6.99M | Buy |
|
|||||
|
2015
Q2 | $8.81M | Buy |
|
|||||
|
2015
Q1 | $7.94M | Buy |
|
|||||
|
2014
Q4 | $7.24M | Sell |
|
|||||
|
2014
Q3 | $7.29M | Sell |
|
|||||
|
2014
Q2 | $7.02M | Buy |
|
|||||
|
2014
Q1 | $5.7M | Sell |
|
|||||
|
2013
Q4 | $5.45M | Sell |
|
|||||
|
2013
Q3 | $4.22M | Sell |
|
|||||
|
2013
Q2 | $3.65M | Buy |
|